Cargando…
The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review
Inflammatory bowel disease (IBD), which affects millions of people worldwide, includes two separate diseases: Crohn’s disease (CD) and ulcerative colitis (UC). Although the background (chronic inflammatory state) and some of the symptoms of CD and UC are similar, both diseases differ from each other...
Autores principales: | Jakubczyk, Dominika, Leszczyńska, Katarzyna, Górska, Sabina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400428/ https://www.ncbi.nlm.nih.gov/pubmed/32630805 http://dx.doi.org/10.3390/nu12071973 |
Ejemplares similares
-
The NLRP3 inflammasome as a new target in respiratory disorders treatment
por: Leszczyńska, Katarzyna, et al.
Publicado: (2022) -
Impact of Probiotic Bacteria on Respiratory Allergy Disorders
por: Jakubczyk, Dominika, et al.
Publicado: (2021) -
Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023) -
COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022) -
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)